CURRICULUM VITAE. Key Qualifications: Clinicaly Cardiology, Invasive Cardiology, Cardiac Electrophisology

Size: px
Start display at page:

Download "CURRICULUM VITAE. Key Qualifications: Clinicaly Cardiology, Invasive Cardiology, Cardiac Electrophisology"

Transcription

1 CURRICULUM VITAE Personal Details Surname: Akbulut First Name: Mehmet Academic title/position: Professor Key Qualifications: Clinicaly Cardiology, Invasive Cardiology, Cardiac Electrophisology Research Interest: Clinicaly Cardiology, Invasive Cardiology, International Experience/Collaborations: Contact Details Work Address: Name of Hospital: Fırat University, Medical Faculty, Departmant of Cardiology Street Town: Elazığ Country: Turkey Post Code: Phone/Fax: (2567) Date of Birth: 01 January 1968 Place and Country of Birth: Elazığ-Sarıçubuk / Turkey Country of Citizenship: TC. Country of Training: Turkey First Language: Turkish Languages: English

2 Academic Details Faculty/University (name and address) Cerrahpaşa Medical Faculty / Đstanbul Üniversity Date of Graduation 1993 Postgraduate Training: (Name and address of Center and Supervisor[s] in charge of Training) Fırat Üniversity, Medical Faculty, Department of Cardiology SUPERVISOR IN CHARGE OF TRAINING: Prof. Dr. Đ. Nadi Arslan From 1995 To 1999 Title of thesis: The Effect of Simvastatin on Diastolic Disfunction Accreditation: (Name, number and date of certificate issued by University, Medical Association or Government Body) Academic Experience: Memberships: Turish Society of Cardiology European Society of Cardiology

3 International Publications: 1. Đlkay, E., I. Karaca, A. Karadaban, A.E. Kılıçoğlu, M. Yalnız, Y. Özbay, A. Karakurt, M. Akbulut and N. Arslan, A Single Center Experience with The Newly Designed R Stent in Small Coronary Vessels, International J of Cardiovascular Interventions, 4, (2001). 2. Đlkay, E., I. Karaca, M. Akbulut, A.E. Kılıçoğlu, Y. Özbay, M. Yavuzkır and N. Arslan, Direct Stenting Application in Acute Coronary Syndromes, International Journal of Angiology, 11, (2002). 3. Karaca, I., E. Đlkay, M. Akbulut and M. Yavuzkır, Treatment of in Stent Restenosis with Excimer Laser Angioplasty, Japanese Heart Journal, 44, (2003). 4. Akbulut, M., Y. Özbay, E. Đlkay, I. Karaca and N. Arslan Effects of Spironolactone and Metoprolol on QT Dispersion in Heart Failure, Japanese Heart Journal, 44 (5), (2003). 5. Karaca, I., E. Đlkay, M. Yavuzkır, M. Akbulut, H. Akbulut, M. Pekdemir and N. Arslan, Atorvastatin Effects c-reactive Protein Levels in Patients with Coronary Artery Disease, Current Medical Research and Opinion, 19 (3), (2003). 6. Đlkay, E., M. Yavuzkır, N. Dağlı, M. Akbulut, I. Karaca and N. Arslan, Stenting of Renal Artery with or without Predilatation in Hypertensive Patients with Renal Artery Stenosis: Results of the Nine Months Follow-up, The Anatolian Journal of Cardiology, 3 (1), 2-7 (2003). 7. Karaca, I., M. Yavuzkır, E. Đlkay, M. Akbulut, A. Rahman and B. Çobanoğlu, Right Atrial Hemangioma (Olgu Sunumu), The Anatolian Journal of Cardiology, 3 (2), 191 (2003). 8. Đlkay, E., I. Karaca, M. Yavuzkır, M. Akbulut and M. Pekdemir, The Effect on ST Resolution of Interventional Treatment in Acute Miyocardial Infarction: A Comparison of Coronary Angioplasty with Excimer Laser Angioplasty, Angiology, 56 (4), (2005). 9. Đlkay, E., M. Yavuzkır, I. Karaca, M. Akbulut, M. Pekdemir and N. Arslan, The Effect of ST Resolution on QT Dispersion After Interventional Treatment in Acute Myocardial Infarction, Clinical Cardiology, 27, (2004). 10. Canatan, H., Đ. Bakan, M. Akbulut, G. Baydaş, Đ. Halifeoğlu and M.F. Gürsu, Comparative Analysis of Plasma Leptin Levels in Both Genders of Patients with Essential Hypertension and Healthy Subjects, Endocrine Research, 30 (1), (2004). 11. Canatan, H., Đ. Bakan, M. Akbulut, Đ. Halifeoğlu, G. Çıkım, G. Baydaş and N. Kılıç, Relationship Among Levels of Leptin and Zinc, Copper, and Zinc/Copper Ratio in Plasma of Patents with Essential Hypertension and Healthy Normotensive Subjects, Biological Trace Element Research, 100 (2), (2004). 12. Akbulut, M., Y. Özbay, I. Karaca, E. Đlkay, Ö. Gündoğdu and N. Arslan, The Effect Long-Term Clopidogrel Use on Neointimal Formation After Percutaneous Coronary Intervention, Coronary Arter Disease, 15 (6), (2004). 13. Akbulut, M., Y. Özbay, Ö. Gündoğdu, N. Dağlı, P. Durukan, E. Đlkay and N. Arslan, Effects of Tirofiban on Acute Systemic Inflammatory Response in Elective Percutaneous Coronary Interventions, Current Medical Research and Opınıon, 20 (11), (2004). 14. Đlkay, E., I. Karaca, M. Akbulut, A.E. Kılıçoğlu, M. Yavuzkır and N. Arslan, Excimer Laser Coronary Angioplasty in Acute Myocardial Infarction, Asian Cardiovascular & Thoracic Annals, 12 (4), (2004). 15. Yılmaz,T., F.S. Erol, H. Yakar, Ü. Köhle, M. Akbulut and M.F. Özveren, Delayed Trigeminocardiyak Reflex Induced By Intraorbital Foreign Body: Case Report, Ophthalmologica, 220(1),65-8 (2006). 16. Karaca I, Aydin K, Yavuzkir M, Ilkay E, Akbulut M, Isik A, and Arslan N, Predictive value of C- reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation, J Int Med Res, 33(4): (2005) 17. Baydas G, Reiter RJ, Akbulut M, Tuzcu M, and Tamer S, Melatonin inhibits neural apoptosis induced by homocysteine in hippocampus of rats via inhibition of cytochrome c translocation and caspase-3 activation and by regulating pro- and anti-apoptotic protein levels, Neuroscience, 135(3): (2005)

4 18. Karaca I, N.Coşkun, M.Yavuzkir, E. Ilkay, N. Dağli, A. Işik, M. Balin, M. Akbulut, and N.Arslan, Effect of diltiazem and metoprolol on left atrial appendix functions in patients with nonvalvular chronic atrial fibrillation, Anadolu Kardiyol Derg, 7(1), (2007). 19. Ozbay Y, M. Akbulut, M. Balin, H. Kayancicek, A. Baydas, and H. Korkmaz. The level of hs-crp in coronary artery ectasia and its response to statin and angiotensin-converting enzyme inhibitor treatment, Mediators Inflamm, (2007). 20. Ozbay Y, S. Aydin, AF. Dagli, M. Akbulut, N. Dagli, N. Kilic, A. Rahman, I. Sahin, V. Polat, HI. Ozercan, N. Arslan, and D. Sensoy. Obestatin is present in saliva: alterations in obestatin and ghrelin levels of saliva and serum in ischemic heart disease, BMB Rep. 41(1),55-61 (2008). Presentations at International Scientific Meetings 1. Akbulut, M., Y. Özkan, I. Karaca, E. Đlkay, A.E. Kılıçoğlu and Y. Özbay, The Relation Between c Reactive Protein and Coronary Artery Lesion in Patients with Unstable Angina Pectoris, Proceedings of the 3 th International Congress on Coronary Artery Disease, Lyon, P282, France, Đlkay, E., I. Karaca, Y. Özbay, A.E. Kılıçoğlu, M. Akbulut, Z. Özdağ and N. Arslan, The Exantric- Consantric Laser Catheter For in Stent Restenosis. Proceedings of the 3 th International Congress on Coronary Artery Disease, Lyon, , Monduzzi, Bologna, Karaca, I., M. Akbulut, A.E. Kılıcoglu, E. Đlkay, M. Pekdemır, Y. Özbay and N. Arslan, Decrease In C-Reactıve Protein Level by Atorvastatin Treatment in Population with Coronary Artery Disease Proceedings of the 4 th International Congress on Coronary Artery Disease, Prague, , Mondozzi, Bologna, Karaca, I., M. Akbulut, A.E. Kılıçoğlu, E. Đlkay, Ö. Gündoğdu and N. Arslan. Troponin T and Coronary Angiography Findings In Patient with Unstable Angina Pectoris, Proceedings of the 4 th International Congress on Coronary Artery Disease, Prague, , Mondozzi, Bologna, Karaca, I., E. Đlkay, F. Đlhan, H. Akbulut, M. Akbulut and N. Arslan, Troponin T and C-Reactive Protein Levels In Patients with Unstable Angina Pectoris, Proceedings of the 4 th International Congress on Coronary Artery Disease, Prague, , Mondozzi, Bologna, Đlkay, E., I Karaca, M. Akbulut, A.E. Kılıcoglu, Y. Özbay, M. Yavuzkır and N. Arslan, Excimer Laser Coronary Angioplasty Applicatıon In Acute Myocardial Infarction, Proceedings of the 4 th International Congress on Coronary Artery Disease, Prague, , Mondozzi, Bologna, Karaca, I., M. Akbulut, A.E. Kılıcoglu, E. Đlkay, Y. Özbay and N. Arslan, Effect Of Amlodipin On Insulin Sensitivity, Glucose and Lipid Metabolism In Hypertensive Population, Proceedings of the 4 th International Congress on Coronary Artery Disease, Prague, , Mondozzi, Bologna, Đlkay, E., I. Karaca, M. Akbulut, A.E. Kılıcoglu, Y. Özbay, M. Yavuzkır and N. Arslan, Direct Stenting Application In Acute Coronary Syndromes, Proceedings of the 4 th International Congress on Coronary Artery Disease, Prague, , Mondozzi, Bologna, Akbulut, M., I. Karaca, E. Đlkay, and N. Arslan, The Effect of Ramipril in Patients with Impaired Glocose Tolerance, 4 th International Congress on Coronary Artery Disease, Prague, Vol. IV, 17, Limed Communication, Đlkay, E., I. Karaca, A.E. Kılıçoğlu and M. Akbulut. Stent Implantation After ELCA In De Novo Lesions, 4 th International Congress on Coronary Artery Disease, Prague, Vol. IV, 106, Limed Communication, 2001.

5 11. Karaca, I., E. Đlkay, A.E. Kılıçoğlu, Y. Özbay, M. Akbulut and N. Arslan. The Increase Left Ventricular Mass by Losartan Therapy, 4 th International Congress on Coronary Artery Disease, Prague, Vol. 4, 67, Limed Communication, Akbulut, M., E. Đlkay, I. Karaca, Y. Özbay and N. Arslan, Proximal Coronary Artery Diameter In Turkish Community, 4 th International Congress on Coronary Artery Disease, Prague, Vol. 4, 118, Limed Communication, Bakan, Đ., H. Canatan, M. Akbulut, G. Baydaş, F. Gürsu, Đ. Halifeoğlu, G. Çıkım and E. Çaylak, Plasma Leptin Levels in Both Gender of Turkish Patients with Essential Hypertension and Healthy Subjects, 24 th Congress of Endocrinology and Metabolic Diseases of Turkey Joint Meeting with the American Association of Clinical Endocrinologists,Đstanbul, Endocrine Practice Supp. for September/October 2001, 78, ACE, Florida, Đlkay, E., M. Yavuzkır, I. Karaca, M. Akbulut, M. Pekdemir and N. Arslan, The Effect of Resolution on QT Dispersion After Interventional Treatment in Acute Myocardial Infarction, Proceedings of the 19 th European Congress of the International Society of Non-Invasive Cardiology, Đstanbul, Vol. 31, 170, Mart Matbacılık, Đstanbul, Çelebi, H., I. Karaca, M. Yavuzkır, E. Đlkay, M. Akbulut, Y. Özbay and N. Arslan, The Abnormalities in The Coagülation Factors in Patients with Essential Hypertension, and Relationship Between Coagülation Abnormalities and End Organ Damage, Proceedings of the 19 th European Congress of the International Society of Non-Invasive Cardiology, Đstanbul, Vol. 31, 188, Mart Matbacılık, Đstanbul, Akbulut, M., Y. Özbay, I. Karaca, E. Đlkay, N. Dağlı and N. Arslan, The Effect of Quinapril on Endothelial Function, 5 th International Congress on Coronary Artery Disease, Florence, Vol. V, 67, Limed Communication, Akbulut, M., Ö. Gündoğdu, Y. Özbay, I. Karaca, E. Đlkay and N. Arslan, Intravascular Ultrasound Application to Normal Coronary Arteries, 5 th International Congress on Coronary Artery Disease, Florence, Vol. V, 183, Limed Communication, Durukan, P., M. Pekdemir, Y. Özbay, I. Karaca, M. Yıldız, M. Akbulut, C. Kavalcı and A. Rahaman, The Relation Between Left Ventricular Wall Stres and QT Dispersion in Hypertensive Urgency Patients, Europen Society of Cardiology Congress 2004, Munich, Vol. XXV, 569, Elsevier, Karaca, I., M. Yavuzkır, E. Đlkay, M. Akbulut, K. Aydın and N. Arslan, Predictive Value of C- Reactive Protein In Patients with Unstable Angina Pectoris Undergoing Coronary Artery Stent Implantation, 74 th Europen Atherosclerosis SocietyCongress, Sevile, W01.40, Spain, Karaca, I., M. Yavuzkır, E. Đlkay, N. Coşkun, M. Akbulut and N. Arslan, Determinants of Left Atrial Appendix Flow Velocity Patients with Chronic Atrial Fibrillation, 16 th Annual Meeting Mediterranean Association of Cardiology and Cardiac Surgery, Bodrum, Vol. VII, B122, Carden Jennings Publishing Company Ltd., Charlottesville, Karaca, I., N. Coşkun, M. Yavuzkır, E. Đlkay, M. Akbulut and N. Arslan, Effect of Diltiazem and Metoprolol Used In Controlling Ventricule On Left Atrial Appendix Functions In Patients with Chronic Non Valvular Atrial Fibrillation, 16 th Annual Meeting Mediterranean Association of Cardiology and Cardiac Surgery, Bodrum, Vol. VII, B128, Carden Jennings Publishing Company Ltd., Charlottesville, Kutlu, M., M. Akbulut, Y. Özbay, M.N. Bilen, Y. Çekici and M.A. Kobat, The Effect of Nebivolol Therapy on QT Dispersion in Congestive Heart Failure, 77 th EAS CONGRESS, Đstanbul, April 26-29, Turkey, 2008.

6 23. Akbulut, M., V. Polat, M.N. Bilen, Y. Ozbay, M. Kutlu, A. Baydaş and Y. Atlaş, The Effect of Clopidogrel on Reperfusion in Acute ST Elevatıng Myocardial Infarction, 77 th EAS CONGRESS, Đstanbul, April 26-29, Turkey, 2008.

CURRICULUM VITAE. Personal Details. Surname: Isik. First Name: Ahmet. Akademic title/ position: Professor of Medicine

CURRICULUM VITAE. Personal Details. Surname: Isik. First Name: Ahmet. Akademic title/ position: Professor of Medicine CURRICULUM VITAE Personal Details Surname: Isik First Name: Ahmet Akademic title/ position: Professor of Medicine Key Qualifications: Internal Medicine Specialist and Romatologist Research Interest: International

More information

4-Deveci F, Akbulut HH, Çelik I, Muz MH Ilhan F. Lymphocyte Subpopulations in Pulmonary Tuberculosis Patients, Mediators Inflamm., 2006;(2);89070.

4-Deveci F, Akbulut HH, Çelik I, Muz MH Ilhan F. Lymphocyte Subpopulations in Pulmonary Tuberculosis Patients, Mediators Inflamm., 2006;(2);89070. CURRICULUM VITAE Personal Details Surname: Muz Frst Name: Mehmet Hamdi Academic title/position: Prof. Dr.- President of Chest Disease Departmant Key Qualifcations: Research Interest: Lung Cancers Đnternational

More information

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,

More information

SUPERVĐSOR ĐN CHARGE OF TRAINING: Şef Dr Kunter Perim

SUPERVĐSOR ĐN CHARGE OF TRAINING: Şef Dr Kunter Perim CURRICULUM VITAE Personal Details Surname: Deveci First Name: Figen Academic title/position: Prof, Departmant of Chest Disease Key Qualifcations: Research Interest: Asthma Bronchiale Đnternational Experience/Collaborations:

More information

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Duration of Dual Antiplatelet Therapy After Coronary Stenting Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are

More information

CURRICULUM VITAE. Personal Details. Surname: Akbulut. Frst Name: Hatice Handan. Academic title/position: Prof, Departmant of Immunology

CURRICULUM VITAE. Personal Details. Surname: Akbulut. Frst Name: Hatice Handan. Academic title/position: Prof, Departmant of Immunology CURRICULUM VITAE Personal Details Surname: Akbulut Frst Name: Hatice Handan Academic title/position: Prof, Departmant of Immunology Key Qualifcations: Research Interest: IFA, Flow cytometry, Evaluation

More information

Prognostic impact of uric acid in patients with stable coronary artery disease

Prognostic impact of uric acid in patients with stable coronary artery disease Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,

More information

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY Dr. Mahesh Vakamudi Professor and Head Department of Anesthesiology, Critical Care and Pain Medicine Sri Ramachandra University INTRODUCTION

More information

Antiplatelet and Antithrombotics From clinical trials to guidelines

Antiplatelet and Antithrombotics From clinical trials to guidelines Antiplatelet and Antithrombotics From clinical trials to guidelines Ashraf Reda, MD, FESC Prof and head of Cardiology Dep. Menofiya University Preisedent of EGYBAC Chairman of WGLVR One of the big stories

More information

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.

More information

California Health and Safety Code, Section 1256.01

California Health and Safety Code, Section 1256.01 California Health and Safety Code, Section 1256.01 1256.01. (a) The Elective Percutaneous Coronary Intervention (PCI) Pilot Program is hereby established in the department. The purpose of the pilot program

More information

R EFERENCES. Summary and conclusions

R EFERENCES. Summary and conclusions R EFERENCES Summary and conclusions 129 S UMMARY AND CONCLUSIONS SUMMARY AND GENERAL DISCUSSION 130 Constant vasodilatation, inhibition of platelet and monocyte adhesion, and local thrombolysis are the

More information

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease Diabetes, prediabetes and cardiovascular disease Classes of recommendations Levels of evidence Recommended treatment targets for patients with diabetes and CAD Definition, classification and screening

More information

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains

More information

CARDIAC RISKS OF NON CARDIAC SURGERY

CARDIAC RISKS OF NON CARDIAC SURGERY CARDIAC RISKS OF NON CARDIAC SURGERY N E W S T U D I E S & N E W G U I D E L I N E S W. B. C A L H O U N, M D, F A C C 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management

More information

RITMIR024 - STEM CELL RESEARCH IN CARDIOLOGY

RITMIR024 - STEM CELL RESEARCH IN CARDIOLOGY 1. SCOPE AND METHODOLOGY 2. REPORT SYNOPSIS 2.1 General Definitions Myoblasts Pluripotent Cells Multipotent Cells Progenitor Cells Role of Stem Cells in Repairing the Heart Stem Cell Therapy Stem Cells

More information

The Bioresorbable Vascular Stent Dr Albert Ko

The Bioresorbable Vascular Stent Dr Albert Ko The Bioresorbable Vascular Stent Dr Albert Ko Dr Albert Ko MB BS, FRACP, FCSANZ Interventional/General Cardiologist Ascot Cardiology Symposium 2013 Treatment Goals for Coronary Artery Disease Relieve of

More information

Malmö Preventive Project. Cardiovascular Endpoints

Malmö Preventive Project. Cardiovascular Endpoints Malmö Preventive Project Department of Clinical Sciences Malmö University Hospital Lund University Malmö Preventive Project Cardiovascular Endpoints End of follow-up: 31 Dec 2008 * Report: 21 June 2010

More information

Cilostazol versus Clopidogrel after Coronary Stenting

Cilostazol versus Clopidogrel after Coronary Stenting Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background

More information

GENERAL HEART DISEASE KNOW THE FACTS

GENERAL HEART DISEASE KNOW THE FACTS GENERAL HEART DISEASE KNOW THE FACTS WHAT IS Heart disease is a broad term meaning any disease affecting the heart. It is commonly used to refer to coronary heart disease (CHD), a more specific term to

More information

The Cardiac Society of Australia and New Zealand

The Cardiac Society of Australia and New Zealand The Cardiac Society of Australia and New Zealand Guidelines on Support Facilities for Coronary Angiography and Percutaneous Coronary Intervention (PCI) including Guidelines on the Performance of Procedures

More information

Fort Hamilton Hospital Specialty: Cardiology Department of Medicine Delineation of Privileges

Fort Hamilton Hospital Specialty: Cardiology Department of Medicine Delineation of Privileges NAME Fort Hamilton Hospital Specialty: Cardiology Department of Medicine Delineation of Privileges GENERAL CARDIOLOGY Required Qualifications for General Cardiology Education/Training/Experience Must have

More information

NOVOSTE BETA-CATH SYSTEM

NOVOSTE BETA-CATH SYSTEM HOSPITAL INPATIENT AND OUTPATIENT BILLING GUIDE FOR THE NOVOSTE BETA-CATH SYSTEM INTRAVASCULAR BRACHYTHERAPY DEVICE This guide is intended solely for use as a tool to help hospital billing staff resolve

More information

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 The cardiometabolic risk syndrome is increasingly recognized

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information

Adult Cardiac Surgery ICD9 to ICD10 Crosswalks

Adult Cardiac Surgery ICD9 to ICD10 Crosswalks 164.1 Malignant neoplasm of heart C38.0 Malignant neoplasm of heart 164.1 Malignant neoplasm of heart C45.2 Mesothelioma of pericardium 198.89 Secondary malignant neoplasm of other specified sites C79.89

More information

CURRICULUM VITAE. Personal Details. Surname: OZDEN First name: Mehmet Academic title/position: Assoc. Prof. Key Qualifications: Infection Immunology

CURRICULUM VITAE. Personal Details. Surname: OZDEN First name: Mehmet Academic title/position: Assoc. Prof. Key Qualifications: Infection Immunology CURRICULUM VITAE Personal Details Surname: OZDEN First name: Mehmet Academic title/position: Assoc. Prof. Key Qualifications: Infection Immunology Research Interest: Infectious Diseases International Experience/Collaborations:

More information

Malmö Preventive Project. Cardiovascular Endpoints

Malmö Preventive Project. Cardiovascular Endpoints Malmö Preventive Project Department of Clinical Sciences Skåne University Hospital, Malmö Lund University Malmö Preventive Project Cardiovascular Endpoints End of follow-up: 30 June 2009 Report: 7 October

More information

Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy. Medical Policy

Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy. Medical Policy Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy File name: Cardiac Rehabilitation (Outpatient Phase II) File code: UM.REHAB.04 Origination: 08/1994 Last Review: 08/2011 Next Review:

More information

Cardiology ARCP Decision Aid August 2014

Cardiology ARCP Decision Aid August 2014 Cardiology ARCP Decision Aid August 2014 The table that follows includes a column for each training year which documents the targets that have to be achieved for a satisfactory ARCP outcome at the end

More information

Antonio Colombo MD on behalf of the SECURITY Investigators

Antonio Colombo MD on behalf of the SECURITY Investigators Second Generation Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy - The SECURITY Randomized Clinical Trial Antonio Colombo MD on behalf of the SECURITY

More information

ECG may be indicated for patients with cardiovascular risk factors

ECG may be indicated for patients with cardiovascular risk factors eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,

More information

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Areas to be covered Historical, current, and future treatments for various cardiovascular disease: Atherosclerosis (Coronary

More information

AVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE

AVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE AVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE To be completed by Staff Cardiologists at an adult cardiac institute/department. INSTRUCTIONS:

More information

Cardiovascular Endpoints

Cardiovascular Endpoints The Malmö Diet and Cancer Study Department of Clinical Sciences Malmö University Hospital Lund University The Malmö Diet and Cancer Study CV-cohort Cardiovascular Endpoints End of follow-up: 31 Dec * Report:

More information

CURRICULUM VITAE. Key Qualifications: Gastroenterology, Hepatology, Pancreatobiliary system

CURRICULUM VITAE. Key Qualifications: Gastroenterology, Hepatology, Pancreatobiliary system CURRICULUM VITAE Personal Details Surname: BAHCECIOGLU First Name: Ibrahim Halil Akademic title/ position: Prof. Dr. Key Qualifications: Gastroenterology, Hepatology, Pancreatobiliary system Research Interest:

More information

LIPID PANEL CHOLESTEROL LIPOPROTEIN, ELECTROPHORETIC SEPARATION LIPOPROTEIN, DIRECT MEASUREMENT (HDL) LDL DIRECT TRIGLYCERIDES

LIPID PANEL CHOLESTEROL LIPOPROTEIN, ELECTROPHORETIC SEPARATION LIPOPROTEIN, DIRECT MEASUREMENT (HDL) LDL DIRECT TRIGLYCERIDES Test Code Test Name CPT CHOL Cholesterol, Serum 82465 HDL HDL, (High Density Lipoprotein) 83718 TRIG Triglycerides, Serum 84478 FTRIG Triglycerides (Fluid) 84478 LIPID Lipid Panel 80061 LDL LDL (Low Density

More information

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. San Diego, California San Diego Marriott Marquis & Marina October 3 5, 2014. Participating Faculty

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. San Diego, California San Diego Marriott Marquis & Marina October 3 5, 2014. Participating Faculty CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE San Diego, California San Diego Marriott Marquis & Marina October 3 5, 2014 Participating Faculty Hector O. Ventura, MD, FACC Section Head, Cardiomyopathy and

More information

Heart Center Packages

Heart Center Packages Heart Center Packages For more information and appointments, Please contact The Heart Center of Excellence at the American Hospital Dubai Tel: +971-4-377-6571 Email: heartcenter@ahdubai.com www.ahdubai.com

More information

Protocol. Cardiac Rehabilitation in the Outpatient Setting

Protocol. Cardiac Rehabilitation in the Outpatient Setting Protocol Cardiac Rehabilitation in the Outpatient Setting (80308) Medical Benefit Effective Date: 07/01/14 Next Review Date: 09/15 Preauthorization No Review Dates: 07/07, 07/08, 05/09, 05/10, 05/11, 05/12,

More information

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology Chapter 4: Endocrine, Nutritional, and Metabolic Diseases (E00-E89) The diabetes mellitus codes are combination codes

More information

Ch. 138 CARDIAC CATHETERIZATION SERVICES 28 138.1 CHAPTER 138. CARDIAC CATHETERIZATION SERVICES GENERAL PROVISIONS

Ch. 138 CARDIAC CATHETERIZATION SERVICES 28 138.1 CHAPTER 138. CARDIAC CATHETERIZATION SERVICES GENERAL PROVISIONS Ch. 138 CARDIAC CATHETERIZATION SERVICES 28 138.1 CHAPTER 138. CARDIAC CATHETERIZATION SERVICES Sec. 138.1 Principle. 138.2. Definitions. GENERAL PROVISIONS PROGRAM, SERVICE, PERSONNEL AND AGREEMENT REQUIREMENTS

More information

Drug-Eluting Balloons. Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam

Drug-Eluting Balloons. Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam Drug-Eluting Balloons Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam Potential conflicts of interest Speaker s name: Klaus Bonaventura

More information

University of Missouri Kansas City School of Medicine and the Mid America Heart Institute of Saint Luke s Hospital

University of Missouri Kansas City School of Medicine and the Mid America Heart Institute of Saint Luke s Hospital PROGRAM DIRECTOR: Dr. Steven Laster University of Missouri Kansas City School of Medicine and the Mid America Heart Institute of Saint Luke s Hospital 1 Interventional Cardiology Fellowship Training Program

More information

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011

More information

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) March 2014 2014 MVP Health Care, Inc. CHAPTER 9 CHAPTER SPECIFIC CATEGORY CODE BLOCKS I00-I02 Acute rheumatic fever I05-I09 Chronic rheumatic heart

More information

Stent for Life Initiative How can we improve system delay and patients delay in STEMI

Stent for Life Initiative How can we improve system delay and patients delay in STEMI Stent for Life Initiative How can we improve system delay and patients delay in STEMI Z. Kaifoszova SFL Initiative Europe 2011 Stent for Life Initiative 10 countries participate in the program Declaration

More information

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease PRECOMBAT Trial Seung-Whan Lee, MD, PhD On behalf

More information

Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses

Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses Diagnosis Code Crosswalk : to 402.01 Hypertensive heart disease, malignant, with heart failure 402.11 Hypertensive heart disease, benign, with heart failure 402.91 Hypertensive heart disease, unspecified,

More information

CURRICULUM VITAE. Research Interest: Gastrointestinal Pathology, Hepato-biliary pathology, Pancreas pathology

CURRICULUM VITAE. Research Interest: Gastrointestinal Pathology, Hepato-biliary pathology, Pancreas pathology CURRICULUM VITAE Personal Details Surname: OZERCAN First Name: Ibrahim Hanifi Academic title/position: Professor Key Qualifications: Research Interest: Gastrointestinal Pathology, Hepato-biliary pathology,

More information

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs A Patient s Guide to Primary and Secondary Prevention of PATIENT EDUCATION GUIDE What Is Cardiovascular Disease? Cardiovascular disease (CVD) is a broad term that covers any disease of the heart and circulatory

More information

Perioperative Cardiac Evaluation

Perioperative Cardiac Evaluation Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project

More information

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Name of the Procedure: Coronary Balloon Angioplasty 2. Select the Indication from the drop down of various indications

More information

Main Effect of Screening for Coronary Artery Disease Using CT

Main Effect of Screening for Coronary Artery Disease Using CT Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,

More information

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation

More information

SAMPLE. Asia-Pacific Interventional Cardiology Procedures Outlook to 2020. Reference Code: GDMECR0061PDB. Publication Date: May 2014

SAMPLE. Asia-Pacific Interventional Cardiology Procedures Outlook to 2020. Reference Code: GDMECR0061PDB. Publication Date: May 2014 Asia-Pacific Interventional Cardiology Procedures Outlook to 2020 Reference Code: GDMECR0061PDB Publication Date: May 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2

More information

INTRODUCTION TO EECP THERAPY

INTRODUCTION TO EECP THERAPY INTRODUCTION TO EECP THERAPY is an FDA cleared, Medicare approved, non-invasive medical therapy for the treatment of stable and unstable angina, congestive heart failure, acute myocardial infarction, and

More information

Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment

Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment What does that mean for you? Your healthcare provider has determined that you may be at risk for cardiovascular disease (CVD).

More information

Cardiovascular Endpoints

Cardiovascular Endpoints The Malmö Diet and Cancer Study Department of Clinical Sciences Skåne University Hospital, Malmö Lund University The Malmö Diet and Cancer Study CV-cohort Cardiovascular Endpoints End of follow-up: 30

More information

NCD for Lipids Testing

NCD for Lipids Testing Applicable CPT Code(s): NCD for Lipids Testing 80061 Lipid panel 82465 Cholesterol, serum or whole blood, total 83700 Lipoprotein, blood; electrophoretic separation and quantitation 83701 Lipoprotein blood;

More information

Appendix. Costing Case Samples for OOHCA

Appendix. Costing Case Samples for OOHCA Appendix Costing Case Samples for OOHCA The patient (ICD-1) Treatment Codes (OPCS 4) Patient 27 Admitted to ICU following percutaneous cardiac intervention (PCI) with 2 drugeluting stents following a VF

More information

Experience of Direct Coronary Stenting at National Institute of Cardiovascular Diseases

Experience of Direct Coronary Stenting at National Institute of Cardiovascular Diseases Experience of Direct Coronary Stenting at National Institute of Cardiovascular Diseases T. Masood,T. Sagheer,D. Jan,N. Qamar,A.M.A. Faruqui ( National Institute of Cardiovascular Diseases (NICVD), Karachi.

More information

CENTRAL MONITORING AUTHORITY for CARDIOLOGY at EU LEVEL

CENTRAL MONITORING AUTHORITY for CARDIOLOGY at EU LEVEL Outline of Cardiology Training Chapter 6 Article 1 CENTRAL MONITORING AUTHORITY for CARDIOLOGY at EU LEVEL 1.1. The central monitoring authority for the specialty will be the European Board for the Specialty

More information

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, 2016. Participating Faculty

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, 2016. Participating Faculty CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE Las Vegas, Nevada Bellagio March 4 6, 2016 Participating Faculty Friday, March 4th: 7:30 am - 8:00 am Registration and Hot Breakfast 8:00 am - 9:00 am Pulmonary

More information

CARDIOLOGY ROTATION GOALS AND OBJECTIVES

CARDIOLOGY ROTATION GOALS AND OBJECTIVES CARDIOLOGY ROTATION GOALS AND OBJECTIVES PGY-1 Core Medicine Rotation The trainee will have the opportunity to develop clinical skills, the ability to analyze patients problems, and make treatment plans

More information

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY American Osteopathic Association and the American College of Osteopathic Internists Specific Requirements For Osteopathic Subspecialty Training In Cardiology

More information

Case Presentation: Mr. E.M. Dr. Braun

Case Presentation: Mr. E.M. Dr. Braun Case Presentation: Mr. E.M. Dr. Braun Case Presentation: Mr. E.M. 66 years old; PMHx CAD with stent 2010; carotid artery disease with stent 1999; aortic stenosis; CVA 1998; type 2 DM; colon cancer with

More information

The Canadian Association of Cardiac

The Canadian Association of Cardiac Reinventing Cardiac Rehabilitation Outside of acute care institutions, cardiovascular disease is a chronic, inflammatory process; the reduction or elimination of recurrent acute coronary syndromes is a

More information

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38 Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac

More information

Medical Tourism - The Role of Intervals inCardiovascular Cancer

Medical Tourism - The Role of Intervals inCardiovascular Cancer Acute Decompensated Heart Failure: Time Critical Interventions MO-51 / 1 Hour Faculty: Matthew Strehlow, MD, FACEP Monday, 10/26/2015 / 3:30 PM - 4:20 PM The treatment of congestive heart failure (CHF)

More information

CARDIOLOGY Delineation of Privileges

CARDIOLOGY Delineation of Privileges CARDIOLOGY Delineation of Privileges APPLICANT: INITIAL APPOINTMENT REQUIREMENTS: BASIC EDUCATION: M.D. or D.O. from an accredited school of medicine or osteopathy. Successful completion of an ACGME or

More information

Listen to your heart: Good Cardiovascular Health for Life

Listen to your heart: Good Cardiovascular Health for Life Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular

More information

Regions Hospital Delineation of Privileges Cardiology

Regions Hospital Delineation of Privileges Cardiology Regions Hospital Delineation of s Cardiology Applicant s Name: Last First M. Instructions: Place a check-mark where indicated for each core group you are requesting. Review education and basic formal training

More information

Cardiac Catheterization Curriculum for Fellows in Cardiology Dartmouth-Hitchcock Medical Center Level 1 and Level 2 Training 2008-2009

Cardiac Catheterization Curriculum for Fellows in Cardiology Dartmouth-Hitchcock Medical Center Level 1 and Level 2 Training 2008-2009 Cardiac Catheterization Curriculum for Fellows in Cardiology Dartmouth-Hitchcock Medical Center Level 1 and Level 2 Training 2008-2009 I. Overview of Training in Cardiac Catheterization Cardiac catheterization

More information

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process

More information

Addendum to Clinical Review for NDA 22-512

Addendum to Clinical Review for NDA 22-512 Addendum to Clinical Review for DA 22-512 Drug: Sponsor: Indication: Division: Reviewers: dabigatran (Pradaxa) Boehringer Ingelheim Prevention of stroke and systemic embolism in atrial fibrillation Division

More information

MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION. POLICY NUMBER: 8.01.14 CATEGORY: Therapy/ Rehabilitation

MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION. POLICY NUMBER: 8.01.14 CATEGORY: Therapy/ Rehabilitation MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy

More information

Coronary angiogram : An author view Patwary MSR

Coronary angiogram : An author view Patwary MSR The ORION Medical Journal 2008 Sep;31:599-601 Coronary angiogram : An author view Patwary MSR Abstract It is relatively safe, though minimally invasive, test. Coronary angiogram is an x-ray of the coronary

More information

MEDICAL POLICY No. 91580-R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE

MEDICAL POLICY No. 91580-R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE Effective Date: October 1, 2015 Review Dates: 10/11, 10/12, 10/13, 8/14, 8/15 Date Of Origin: October 12, 2011 Status: Current Summary of Changes Clarifications:

More information

Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism

Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of

More information

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:

More information

Interventional Cardiology Peripheral Interventions Rhythm Management

Interventional Cardiology Peripheral Interventions Rhythm Management FY2016 Hospital Inpatient Rule (IPPS) Interventional Cardiology Peripheral Interventions Rhythm Management On April 17, 2015 the Centers for Medicare and Medicaid Services (CMS) released the Hospital Inpatient

More information

Curriculum on Inpatient Cardiology Internal Medicine Residency Program Ochsner Clinic Foundation

Curriculum on Inpatient Cardiology Internal Medicine Residency Program Ochsner Clinic Foundation Curriculum on Inpatient Cardiology Internal Medicine Residency Program Ochsner Clinic Foundation Authors: Bijesh Maroo MD David Elizardi MD, FACC Hector Ventura MD, FACC This document was created with

More information

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical

More information

Automatic External Defibrillators

Automatic External Defibrillators Last Review Date: May 27, 2016 Number: MG.MM.DM.10dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

Atherosclerosis of the aorta. Artur Evangelista

Atherosclerosis of the aorta. Artur Evangelista Atherosclerosis of the aorta Artur Evangelista Atherosclerosis of the aorta Diagnosis Classification Prevalence Risk factors Marker of generalized atherosclerosis Risk of embolism Therapy Diagnosis Atherosclerosis

More information

CURRICULUM VITAE Prof. ANTONIO CURNIS

CURRICULUM VITAE Prof. ANTONIO CURNIS CURRICULUM VITAE Prof. ANTONIO CURNIS I. Personal Informations - Born in February 11 th 1958 in Bergamo (Italy). - Graduated by University of Brescia 23.10.88 - Division of Cardiology of Civil Hospital

More information

Q1: Global risk assessment using PROCAM, SCORE, FRAMINGHAM or REYNOLDS ecc is sufficient YES NO NEED MORE DATA DISCUSS within Taskforce Your Comments

Q1: Global risk assessment using PROCAM, SCORE, FRAMINGHAM or REYNOLDS ecc is sufficient YES NO NEED MORE DATA DISCUSS within Taskforce Your Comments Site ID: Q1: Global risk assessment using PROCAM, SCORE, FRAMINGHAM or REYLDS ecc is sufficient Q2: The value of an emerging test is best assessed using C - statistics Q3: Atherosclerosis imaging may be

More information

Guidelines for Use of Clopidogrel (Plavix )

Guidelines for Use of Clopidogrel (Plavix ) East Lancashire Medicines Management Board representing East Lancashire Hospitals NHS Trust, Lancashire Care Trust, Blackburn with Darwen PCT, East Lancs PCT Licensed Indications Guidelines for Use of

More information

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients

More information

Post-MI Cardiac Rehabilitation. Mark Mason Consultant Cardiologist Harefield Hospital Royal Brompton and Harefield NHS Foundation Trust

Post-MI Cardiac Rehabilitation. Mark Mason Consultant Cardiologist Harefield Hospital Royal Brompton and Harefield NHS Foundation Trust Post-MI Cardiac Rehabilitation Mark Mason Consultant Cardiologist Harefield Hospital Royal Brompton and Harefield NHS Foundation Trust 'the sum of activities required to influence favourably the underlying

More information

Rx Updates New Guidelines, New Medications What You Need to Know

Rx Updates New Guidelines, New Medications What You Need to Know Rx Updates New Guidelines, New Medications What You Need to Know Maria Pruchnicki, PharmD, BCPS, BCACP, CLS Associate Professor of Clinical Pharmacy OSU College of Pharmacy Background scope and impact

More information

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT

More information

LCD L30256 - C-Reactive Protein High Sensitivity Testing (hscrp)

LCD L30256 - C-Reactive Protein High Sensitivity Testing (hscrp) LCD L30256 - C-Reactive Protein High Sensitivity Testing (hscrp) Contractor Information Contractor Name: Novitas Solutions, Inc. Contractor Number(s): 12501, 12101, 12102, 12201, 12202, 12301, 12302, 12401,

More information

MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY

MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY In order to improve the efficiency of PINNACLE Registry data analytics, a missing data analysis has been conducted on PINNACLE Registry data

More information

Purpose Members of the Department of Cardiology will provide cardiology services to patients of McLaren Greater Lansing.

Purpose Members of the Department of Cardiology will provide cardiology services to patients of McLaren Greater Lansing. Purpose Members of the Department of Cardiology will provide cardiology services to patients of McLaren Greater Lansing. Qualifications To be eligible for core privileges in the Department of Cardiology,

More information

Renovascular Hypertension

Renovascular Hypertension Renovascular Hypertension Philip Stockwell, MD Assistant Professor of Medicine (Clinical) Warren Alpert School of Medicine Cardiology for the Primary Care Provider September 28, 201 Renovascular Hypertension

More information

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts Cardiac Rehabilitation: From the other side of the glass door No disclosures, no conflicts Charles X. Kim, MD, FACC, ABVM Objectives 1. Illustrate common CV benefits of CV rehab in real world practice.

More information

LEADING-EDGE Cardiovascular Care

LEADING-EDGE Cardiovascular Care LEADING-Edge Cardiovascular Care Coral Gables Hospital North Shore Medical Center Hialeah Hospital Delray Medical Center Good Samaritan Medical Center Palm Beach Gardens Medical Center St. Mary s Medical

More information